A kind of prescription for removing blood stasis and lowering turbidity for treating gout

Abstract

The invention relates to the field of traditional Chinese medicine preparations, in particular to a formula for removing blood stasis and reducing turbidity for treating gout, which is composed of the following raw materials: stir-fried Atractylodes Rhizoma, Achyranthes chinensis, Phellodendron rhizome, stir-fried Coix seed, Angelica sinensis, Rehmannia glutinosa, Chuanxiong, stir-fried Atractylodes Rhizoma, Poria, psyllium, licorice, salvia, rhubarb. The medicines of the present invention play a role of invigorating the spleen and invigorating the middle, removing blood stasis and removing dampness, consolidating the root and removing blood stasis, and can effectively relieve the symptoms of patients, and can effectively reduce uric acid and blood lipids, have few adverse reactions, are not easy to induce gout, and have satisfactory clinical effects.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine preparations, in particular to a stasis-removing and turbid-removing formula for treating gout. Background technique [0002] Gout is a clinical syndrome in which purine metabolism is abnormal in the body due to metabolic and genetic factors, serum uric acid concentration increases, and monosodium urate crystals are chronically deposited in joint capsule, bursa, cartilage, bone and other tissues, causing inflammatory reactions and clinical syndromes. , which is directly related to hyperuricemia caused by decreased uric acid excretion and / or disorder of purine metabolism, and is the second largest metabolic disease in my country. With the improvement of social and economic level and people's living standards, the prevalence of gout is increasing year by year and the age of onset tends to be younger. If the disease is improperly treated and repeated, it can lead to complications such as u...

AI Technical Summary

Problems solved by technology

Although Western medicine can effectively reduce uric acid levels, control acute attacks, and relieve clinical symptoms in terms of treatment, there are still some deficiencies: ①The timing, target and possible adverse effects of uric acid lowering are still controversial; ②In clinical practice, the initial application of urate-lowering drugs is likely to lead to acute recurrence of gout symptoms, and lowering urate can not effectively prevent the recurrence of gout. Some studies have shown that febuxostat and allopurinol are effective in the treatment of urate-lowering for one year. , 53% of patients had their SUA controlled at ≤6mg·dL -1 , but the recurrence rate of gout is still 63%

③The incidence of adverse reactions of long-term medication is high

Images